Senores Pharmaceuticals Profit & Loss Annual

BSE: 544319 | NSE: SENORES | ISIN: INE0RB801010 | Sector: Biotechnology & Drugs

1,510.00 +13.50 (0.90%)Updated : 08 Sep 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	495.56	325.39	182.92	24.29
Other Net	47.06	7.49	1.75	0.26
Total Adjustmentsto Net Income	0.10	-	-	-
Diluted Weighted Average Shares	4.37	3.64	3.33	3.33
Depreciation/ Amortization	31.25	16.84	10.02	1.78
Operating Income	137.07	72.86	31.61	11.05
Net Income	115.37	58.56	31.46	8.43
Income Availableto Com Excl Extra Ord	115.38	58.56	31.46	8.43
Other Operating Expenses Total	100.40	39.10	21.72	4.50
Net Income Before Taxes	159.10	70.57	24.94	12.44
Minority Interest	-6.16	0.22	-1.25	-
Net Income After Taxes	121.53	58.34	32.71	8.43
Income Availableto Com Incl Extra Ord	115.38	58.56	31.46	8.43
Costof Revenue Total	251.66	195.98	111.57	12.77
Gross Profit	380.97	202.27	102.96	22.57
Interest Inc( Exp) Net- Non- Op Total	-25.03	-9.78	-8.38	1.28
Diluted Net Income	115.38	58.56	31.46	8.43
Provisionfor Income Taxes	37.57	12.23	-7.76	4.00
period Type	-	-	-	-
Net Income Before Extra Items	115.37	58.56	31.46	8.43
Total Revenue	632.63	398.25	214.52	35.34
period Length	12.00	12.00	12.00	12.00
Revenue	632.63	398.25	214.52	35.34
Selling/ General/ Admin Expenses Total	112.25	72.98	39.62	5.24
Diluted Normalized EPS	26.39	16.10	9.46	2.57
Diluted EPS Excluding Extra Ord Items	26.39	16.10	9.46	2.54
Gain( Loss)on Saleof Assets	-	0.00	-0.03	-0.16
Research Development	-	0.49	-	-

*All figures in crores except per share values

Trending Stocks

410.50+6.00(1.48%)

1,708.85+17.85(1.06%)

1,982.50+16.50(0.84%)

1,399.50-28.50 (-2.00%)

1,245.45-21.85 (-1.72%)

Related News